Profile data is unavailable for this security.
About the company
Fidson Healthcare Plc is a Nigeria-based pharmaceutical manufacturing company. The principal activities of the Company include the manufacturing and distribution of pharmaceutical products. The Company's segments include over-the-counter, ethical products, and consumer healthcare. The over-the-counter segment represents the products that may be sold directly to the consumer without a prescription. The ethical products segment represents drugs, injectables and infusions, which are sold to the consumer only on the possession of a valid prescription. The consumer segment represents manufacturing products for customers. It provides services, including formulation/development, contract manufacturing, and production of medicines. Its products include Anti-Infective and Anti-Malaria, Central Nervous System, Gastrointestinal Medicines, Topical/Dermatological Medicines, Vitamins and Minerals, Ophthalmic Solution, and others. Its Ophthalmic Solution helps manage and treat eye conditions.
- Revenue in NGN (TTM)119.06bn
- Net income in NGN9.31bn
- Incorporated1995
- Employees674.00
- LocationFidson Healthcare PLC268, Ikorodu Road, ShomoluP.O.Box 7210LAGOS NigeriaNGA
- Phone+234 3429102
- Fax+234 3429106
- Websitehttps://www.fidson.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Karyopharm Therapeutics Inc | 202.16bn | -271.32bn | 232.30bn | 228.00 | -- | -- | -- | 1.15 | -16.60 | -16.60 | 13.36 | -16.00 | 1.07 | 1.36 | 5.13 | 640,644.80 | -143.71 | -55.11 | -442.98 | -78.19 | 95.93 | 96.83 | -134.21 | -87.65 | 1.08 | -2.11 | 47.44 | -- | 0.5715 | 6.21 | -156.52 | -- | -- | -- |
| Fidson Healthcare PLC | 119.06bn | 9.31bn | 234.49bn | 674.00 | 21.11 | 6.04 | 20.31 | 1.97 | 3.84 | 3.84 | 48.81 | 13.41 | 1.55 | 2.77 | 13.82 | -- | 12.09 | 10.02 | 26.14 | 19.32 | 41.28 | 41.98 | 7.82 | 8.12 | 0.5243 | 2.13 | 0.5217 | -- | 41.42 | 45.47 | 61.05 | 50.51 | 31.56 | -- |
| Beijing Biostar Pharmaceuticals Co Ltd | -17.70tn | -17.70tn | 235.58bn | 147.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 7.85 | -- | 24.19 | -- | -- | -- |
| Windlas Biotech Ltd | 130.45bn | 10.03bn | 239.30bn | 1.35k | 24.02 | -- | 16.28 | 1.83 | 31.46 | 31.46 | 409.16 | -- | -- | -- | -- | 6,450,929.00 | -- | 8.65 | -- | 11.81 | 38.34 | 34.09 | 7.69 | 7.70 | -- | 15.80 | -- | 18.33 | 20.43 | 18.24 | 4.82 | 30.34 | 27.99 | -- |
